Symetis  ||| S:0 E:8 ||| NNP
ACURATE  ||| S:8 E:16 ||| NNP
TA  ||| S:16 E:19 ||| NNP
valve  ||| S:19 E:25 ||| VBD
The  ||| S:25 E:29 ||| DT
transcatheter  ||| S:29 E:43 ||| FW
aortic  ||| S:43 E:50 ||| FW
valve  ||| S:50 E:56 ||| FW
prosthesis  ||| S:56 E:67 ||| FW
ACURATE  ||| S:67 E:75 ||| NNP
TA  ||| S:75 E:78 ||| NNP
( ||| S:78 E:79 ||| -LRB-
Symetis  ||| S:79 E:87 ||| NNP
SA ||| S:87 E:89 ||| NNP
,  ||| S:89 E:91 ||| ,
Ecublens ||| S:91 E:99 ||| NNP
,  ||| S:99 E:101 ||| ,
Switzerland ||| S:101 E:112 ||| NNP
)  ||| S:112 E:114 ||| -RRB-
has  ||| S:114 E:118 ||| VBZ
been  ||| S:118 E:123 ||| VBN
specifically  ||| S:123 E:136 ||| RB
designed  ||| S:136 E:145 ||| VBN
for  ||| S:145 E:149 ||| IN
transapical  ||| S:149 E:161 ||| JJ
access  ||| S:161 E:168 ||| NN
with  ||| S:168 E:173 ||| IN
a  ||| S:173 E:175 ||| DT
future  ||| S:175 E:182 ||| JJ
transfemoral  ||| S:182 E:195 ||| JJ
version  ||| S:195 E:203 ||| NN
under  ||| S:203 E:209 ||| IN
development ||| S:209 E:220 ||| NN
.  ||| S:220 E:222 ||| .
The  ||| S:222 E:226 ||| DT
concept  ||| S:226 E:234 ||| NN
relies  ||| S:234 E:241 ||| VBZ
on  ||| S:241 E:244 ||| IN
a  ||| S:244 E:246 ||| DT
self-expandable  ||| S:246 E:262 ||| JJ
nitinol  ||| S:262 E:270 ||| JJ
stent  ||| S:270 E:276 ||| JJ
housing  ||| S:276 E:284 ||| NN
a  ||| S:284 E:286 ||| DT
regular  ||| S:286 E:294 ||| JJ
porcine  ||| S:294 E:302 ||| JJ
bioprosthesis ||| S:302 E:315 ||| NN
.  ||| S:315 E:317 ||| .
A  ||| S:317 E:319 ||| DT
unique  ||| S:319 E:326 ||| JJ
two-step  ||| S:326 E:335 ||| JJ
implantation  ||| S:335 E:348 ||| FW
technique  ||| S:348 E:358 ||| FW
facilitates  ||| S:358 E:370 ||| FW
intuitive  ||| S:370 E:380 ||| FW
positioning ||| S:380 E:391 ||| FW
.  ||| S:391 E:393 ||| .
Two  ||| S:393 E:397 ||| CD
pre-approval  ||| S:397 E:410 ||| JJ
multicentre  ||| S:410 E:422 ||| JJ
trials  ||| S:422 E:429 ||| NNS
have  ||| S:429 E:434 ||| VBP
demonstrated  ||| S:434 E:447 ||| VBN
promising  ||| S:447 E:457 ||| JJ
results  ||| S:457 E:465 ||| NNS
especially  ||| S:465 E:476 ||| RB
as  ||| S:476 E:479 ||| RB
regards  ||| S:479 E:487 ||| VBZ
a  ||| S:487 E:489 ||| DT
low  ||| S:489 E:493 ||| JJ
rate  ||| S:493 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
paravalvular  ||| S:501 E:514 ||| JJ
leaks ||| S:514 E:519 ||| NNS
.  ||| S:519 E:521 ||| .
The  ||| S:521 E:525 ||| DT
device  ||| S:525 E:532 ||| NN
obtained  ||| S:532 E:541 ||| VBD
CE  ||| S:541 E:544 ||| NNP
mark  ||| S:544 E:549 ||| NN
at  ||| S:549 E:552 ||| IN
the  ||| S:552 E:556 ||| DT
end  ||| S:556 E:560 ||| NN
of  ||| S:560 E:563 ||| IN
2011  ||| S:563 E:568 ||| CD
and  ||| S:568 E:572 ||| CC
is  ||| S:572 E:575 ||| VBZ
currently  ||| S:575 E:585 ||| RB
commercially  ||| S:585 E:598 ||| RB
available  ||| S:598 E:608 ||| JJ
in  ||| S:608 E:611 ||| IN
Europe ||| S:611 E:617 ||| NNP
.  ||| S:617 E:619 ||| .
This  ||| S:619 E:624 ||| DT
manuscript  ||| S:624 E:635 ||| NN
focuses  ||| S:635 E:643 ||| VBZ
on  ||| S:643 E:646 ||| IN
the  ||| S:646 E:650 ||| DT
technical  ||| S:650 E:660 ||| JJ
details  ||| S:660 E:668 ||| NNS
of  ||| S:668 E:671 ||| IN
this  ||| S:671 E:676 ||| DT
new  ||| S:676 E:680 ||| JJ
transapical  ||| S:680 E:692 ||| JJ
TAVI  ||| S:692 E:697 ||| NNP
device  ||| S:697 E:704 ||| NN
and  ||| S:704 E:708 ||| CC
its  ||| S:708 E:712 ||| PRP$
specific  ||| S:712 E:721 ||| JJ
implantation  ||| S:721 E:734 ||| JJ
technique ||| S:734 E:743 ||| NN
.  ||| S:743 E:745 ||| .
